• Supervisory Board member

    Dr Nuala Murphy was appointed to the board of Cerba HealthCare in 2023, in addition to assuming the chair of the ESG committee and executive chair of Cerba Research. 

     

    With a background in drug development, Nuala is a strategic advisor to private equity, having held leadership & board roles in the pharmaceutical sector, most recently as President of Drug development and Commercialization at ICON Plc. 

     

    Nuala graduated from Trinity College Dublin, was awarded a PhD from the School of Medicine at the University of Leeds, a post-doctorate in neuroscience from the Collège de France, Paris, a diploma in ESG from the Corporate Governance Institute and was certified in corporate governance at INSEAD.